Home/Genenta Science/Gregory L. Bell
GL

Gregory L. Bell

Chief Financial Officer

Genenta Science

Genenta Science Pipeline

DrugIndicationPhase
TemferonNewly Diagnosed Unmethylated Glioblastoma Multiforme (GBM)Phase 1/2